TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32737577

Group type: COMPARATOR
Intervention: Oral dexamethasone (2.5 mg on two successive days a week)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (up to 2 g for 180 days)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both interventions (dexamethasone and mycophenolate)
Number of subjects: 50
Study: 35210348

Group type: EXPERIMENTAL
Intervention: 2 g of intravenous TXA administered intraoperatively
Number of subjects: 1230

Group type: COMPARATOR
Intervention: Placebo (saline) administered intraoperatively
Number of subjects: 1230
Study: 33490018

Group type: EXPERIMENTAL
Intervention: HPHB intervention (a combination of health and parenting intervention augmenting routine ultrasound)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine ultrasound (US)
Number of subjects: 0
Study: 35191746

Group type: EXPERIMENTAL
Intervention: JS016 plus standard care
Number of subjects: 199

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 199
Study: 33705547

Group type: EXPERIMENTAL
Intervention: Endogenous estradiol genetically predicted by variants in the CYP19A1 gene region
Number of subjects: 170593

Group type: EXPERIMENTAL
Intervention: Genetic variants in the JMJD1C gene (predictor of high endogenous testosterone)
Number of subjects: 170593
Study: 33880495

Group type: EXPERIMENTAL
Intervention: Substitution of 1% of SFAs for 1% of linoleic acid
Number of subjects: 1252

Group type: EXPERIMENTAL
Intervention: Substitution of 1% of marine n‐3 PUFA DHA for linoleic acid
Number of subjects: 1252
Study: 33284796

Group type: EXPERIMENTAL
Intervention: Normal (0.011 ml supplement/kg bodyweight)
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: High (0.063 ml supplement/kg bodyweight)
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Silicon supplementation
Number of subjects: 375

Group type: COMPARATOR
Intervention: Control (no supplement)
Number of subjects: 375
Study: 34863673

Group type: EXPERIMENTAL
Intervention: Video-Assisted Peer Feedback (VAPF)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Qualified Instructor Feedback (QIF)
Number of subjects: 251
Study: 32238086

Group type: EXPERIMENTAL
Intervention: Lower seat height (5.08 cm below lower-leg length)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Higher seat heights
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All seat heights tested
Number of subjects: 50
Study: 32352877

Group type: EXPERIMENTAL
Intervention: Global Postural Re-education (GPR)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Stretching exercises (SG)
Number of subjects: 39
Study: 35930291

Group type: EXPERIMENTAL
Intervention: Erect sitting posture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Slouched sitting posture
Number of subjects: 0
Study: 33038227

Group type: EXPERIMENTAL
Intervention: Convalescent Plasma (CP)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control
Number of subjects: 241
Study: 32362349

Group type: EXPERIMENTAL
Intervention: Betrixaban
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard enoxaparin prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35066950

Group type: EXPERIMENTAL
Intervention: Sesame Oil (SO)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Canola Oil (CO)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Sesame-Canola Oil (SCO)
Number of subjects: 77
Study: 33158717

Group type: EXPERIMENTAL
Intervention: Shufeng Jiedu capsules (SFJDC) added to standard antiviral therapy (AVD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Shufeng Jiedu capsules (SFJDC)
Number of subjects: 0
Study: 33161148

Group type: EXPERIMENTAL
Intervention: Exercise facilitator intervention (EFI)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 449
Study: 32238262

Group type: COMPARATOR
Intervention: Antibiotic-impregnated shunt
Number of subjects: 1605

Group type: EXPERIMENTAL
Intervention: Standard shunt
Number of subjects: 1605

Group type: EXPERIMENTAL
Intervention: Silver-impregnated shunt
Number of subjects: 1605
Study: 35189953

Group type: EXPERIMENTAL
Intervention: Gabapentin 900 mg/day for 10 weeks
Number of subjects: 84
Study: 32924674

Group type: COMPARATOR
Intervention: current HPD fit-training method
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: experiential HPD (eHPD) fit-training method
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: integrated fit-training method
Number of subjects: 341
Study: 32167131

Group type: EXPERIMENTAL
Intervention: Borage oil (BO) supplementation (37% LA and 23% GLA) for 4 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Soybean oil (SO) supplementation (50% LA and 0% GLA) for 4 weeks
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Borage oil (BO) supplementation
Number of subjects: 64
Study: 33764243

Group type: EXPERIMENTAL
Intervention: Metaheuristic algorithms (ant colony optimization, simulated annealing, genetic algorithm, large neighborhood search, greedy randomized adaptive search procedures)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GIS approaches
Number of subjects: 0
Study: 34126269

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation
Number of subjects: 346

Group type: COMPARATOR
Intervention: Contact force–guided radiofrequency ablation
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: ERAT presence
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: ERAT timing
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: ERAT burden
Number of subjects: 346
Study: 32718816

Group type: EXPERIMENTAL
Intervention: RSVΔG vaccine (6.5 log10 CCID50)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 35321334

Group type: EXPERIMENTAL
Intervention: Down-regulation ovulation-induction (DROI)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Hormone replacement treatment (HRT)
Number of subjects: 330
Study: 32753547

Group type: EXPERIMENTAL
Intervention: First-line pembrolizumab
Number of subjects: 234
Study: 36495282

Group type: EXPERIMENTAL
Intervention: pFMI (90-µg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CSF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: pFMI (fasted)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: pFMI (fed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CSF (fasted)
Number of subjects: 0
Study: 34455726

Group type: EXPERIMENTAL
Intervention: Lettuce seed syrup (5 mL twice daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo syrup (5 mL twice daily)
Number of subjects: 50
Study: 32910478

Group type: EXPERIMENTAL
Intervention: Pembrolizumab administered after CRT (arm 1)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Pembrolizumab administered during CRT (arm 2)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Both arms (arm 1 and arm 2)
Number of subjects: 52
Study: 35368220

Group type: EXPERIMENTAL
Intervention: Papaverine
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 96
Study: 34329541

Group type: EXPERIMENTAL
Intervention: Immediate urinary catheter removal
Number of subjects: 2

Group type: COMPARATOR
Intervention: Prolonged indwelling catheterization (control)
Number of subjects: 2
Study: 34476445

Group type: EXPERIMENTAL
Intervention: Improved atraumatic restorative treatment (ART) with high-intensity glass ionomer cement
Number of subjects: 262

Group type: COMPARATOR
Intervention: Conventional cavity preparation and composite resin filling (Control)
Number of subjects: 262
Study: 35863061

Group type: EXPERIMENTAL
Intervention: 3-month DAPT
Number of subjects: 488

Group type: COMPARATOR
Intervention: 6-month DAPT
Number of subjects: 488
Study: 34639778

Group type: EXPERIMENTAL
Intervention: 30 s phenol application
Number of subjects: 27

Group type: COMPARATOR
Intervention: 60 s phenol application
Number of subjects: 27
Study: 32895339

Group type: EXPERIMENTAL
Intervention: Multi Interventional Package (MIP) including reflexology foot massage, dietary modification, moderate intensity exercise, and structured education for 12 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lifestyle Interventions (LI) including dietary modification, moderate intensity exercise, and structured education for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group receiving routine care
Number of subjects: 60
Study: 34767321

Group type: EXPERIMENTAL
Intervention: Penicillin G benzathine injections every 4 weeks for 2 years
Number of subjects: 916

Group type: COMPARATOR
Intervention: No prophylaxis (control group)
Number of subjects: 916
Study: 33935089

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS over the right DLPFC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS over the left DLPFC
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no tDCS)
Number of subjects: 40
Study: 32429865

Group type: EXPERIMENTAL
Intervention: Household size
Number of subjects: 30960

Group type: EXPERIMENTAL
Intervention: Sex (female)
Number of subjects: 30960

Group type: EXPERIMENTAL
Intervention: Living with both parents
Number of subjects: 30960

Group type: EXPERIMENTAL
Intervention: Income quartile (2nd)
Number of subjects: 30960

Group type: EXPERIMENTAL
Intervention: Income quartile (4th)
Number of subjects: 30960

Group type: EXPERIMENTAL
Intervention: Age (5 to 9 years)
Number of subjects: 30960

Group type: EXPERIMENTAL
Intervention: Age (15 to 18 years)
Number of subjects: 30960

Group type: EXPERIMENTAL
Intervention: Residency in a non-owned or non-tenancy house
Number of subjects: 30960
Study: 33930353

Group type: EXPERIMENTAL
Intervention: CABG-Ring group
Number of subjects: 102

Group type: COMPARATOR
Intervention: CABG-alone group
Number of subjects: 102
Study: 36482520

Group type: EXPERIMENTAL
Intervention: 500 mg of glucosyl hesperidin per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1000 mg of glucosyl hesperidin per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glucosyl hesperidin
Number of subjects: 0
Study: 32460904

Group type: EXPERIMENTAL
Intervention: Acute stress induction
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 85
Study: 32719880

Group type: EXPERIMENTAL
Intervention: Prototype EHR application
Number of subjects: 13

Group type: COMPARATOR
Intervention: Regular EHR
Number of subjects: 13
Study: 36375587

Group type: EXPERIMENTAL
Intervention: Optic capture without anterior vitrectomy (group 1)
Number of subjects: 37

Group type: COMPARATOR
Intervention: In-the-bag IOL with anterior vitrectomy (group 2)
Number of subjects: 37
Study: 32970236

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study: 32077470

Group type: EXPERIMENTAL
Intervention: GIP(3‐30)NH2+exendin(9‐39)NH2
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: GIP(3‐30)NH2
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: exendin(9‐39)NH2
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 33431616

Group type: EXPERIMENTAL
Intervention: Mepivacaine 1.5%
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 30
Study: 36143083

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) intervention, 12 weeks, 3 sessions per week, 18 min per session (3 sets of 8 bouts of 15 s run at 100% MAS, separated by 8 bouts of 15 s recovery run at 50% MAS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (normal behaviors)
Number of subjects: 40
Study: 33645906

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 12
Study: 32739495

Group type: EXPERIMENTAL
Intervention: Combination of Anakinra (100 mg daily for 14 days), Pentoxifylline (400 mg three times a day for 28 days), and Zinc sulfate (220 mg orally once daily for 6 months)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard of care therapy including Methylprednisolone (32 mg orally once daily for 28 days)
Number of subjects: 104
Study: 35143513

Group type: COMPARATOR
Intervention: Arm 2: access to ARMADILLO SMS information pushed to their phone
Number of subjects: 712

Group type: COMPARATOR
Intervention: Arm 1: access to ARMADILLO’s SMS information on-demand
Number of subjects: 712

Group type: EXPERIMENTAL
Intervention: Control (no SMS)
Number of subjects: 712
Study: 34045241

Group type: EXPERIMENTAL
Intervention: Dietary Glycemic Index (GI)
Number of subjects: 1279

Group type: EXPERIMENTAL
Intervention: Dietary Glycemic Load (GL)
Number of subjects: 1279

Group type: EXPERIMENTAL
Intervention: Fiber
Number of subjects: 1279
Study: 32365232

Group type: EXPERIMENTAL
Intervention: Individualized treatment rules (ITRs) using information from electronic health records (EHRs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Q-learning and modified matched-learning algorithm for estimation
Number of subjects: 0
Study: 35133630

Group type: EXPERIMENTAL
Intervention: SleepLife® intervention (education on using the SleepLife® application and access to the SleepLife® portal)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: SleepLife® intervention
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control arm (no education on using the SleepLife® application)
Number of subjects: 75
Study: 33221914

Group type: EXPERIMENTAL
Intervention: MAP of 40-50 mmHg during CPB
Number of subjects: 193

Group type: COMPARATOR
Intervention: MAP of 70-80 mmHg during CPB
Number of subjects: 193
Study: 32045662

Group type: EXPERIMENTAL
Intervention: Participation in AIRWAYS-2 trial
Number of subjects: 1523

Group type: EXPERIMENTAL
Intervention: Study training and support
Number of subjects: 1523

Group type: EXPERIMENTAL
Intervention: Randomised method of airway management
Number of subjects: 1523

Group type: EXPERIMENTAL
Intervention: Stepwise approach to airway management
Number of subjects: 1523
Study: 35432984

Group type: EXPERIMENTAL
Intervention: Colchicine add on treatment (1 mg daily for 7 days, then 0.5 mg daily for another 7 days)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Colchicine add on treatment
Number of subjects: 160
Study: 32591933

Group type: EXPERIMENTAL
Intervention: Group A (intervention) received reminders for physical activity adherence.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group B (control) did not receive reminders.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group A (intervention) for muscle strengthening activity.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group B (control) for muscle strengthening activity.
Number of subjects: 0
Study: 35272871

Group type: EXPERIMENTAL
Intervention: Physical exercise program and health education program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 36113902

Group type: EXPERIMENTAL
Intervention: Imagery rescripting of an aversive memory
Number of subjects: 52

Group type: COMPARATOR
Intervention: Progressive relaxation (control condition)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Imagery rescripting
Number of subjects: 52
Study: 34374687

Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 114

Group type: COMPARATOR
Intervention: CEE + MPA
Number of subjects: 114

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 114
Study: 35461618

Group type: EXPERIMENTAL
Intervention: Debridement with device group (InSpace balloon)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Debridement only group
Number of subjects: 117
Study: 34246301

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D [25(OH)D] concentration
Number of subjects: 0
Study: 35412076

Group type: EXPERIMENTAL
Intervention: Web-based education program for 3 months
Number of subjects: 60
Study: 34471446

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) stimulation near the cervical sympathetic ganglion at 2 Hz
Number of subjects: 20
Study: 35139330

Group type: EXPERIMENTAL
Intervention: Early surgery (within 3 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed surgery
Number of subjects: 0
Study: 32816626

Group type: EXPERIMENTAL
Intervention: Combination of olive fruit extract (7.5 mg HT) and almond skin extracts (210 mg ASPs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 0
Study: 32356027

Group type: EXPERIMENTAL
Intervention: Vaginal probiotic gel with L. plantarum YUN‐V2.0, L. pentosus YUN‐V1.0 and L. rhamnosus YUN‐S1.0 for 10 consecutive days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vaginal probiotic gel
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Women needing rescue treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clinical composite score
Number of subjects: 20
Study: 35306584

Group type: COMPARATOR
Intervention: Regular PPE
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: COVID‐19 PPE
Number of subjects: 10
Study: 36403132

Group type: EXPERIMENTAL
Intervention: Sutimlimab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34218922

Group type: COMPARATOR
Intervention: Mixed tocopherols (TMIX) at 0, 5, 10, or 15 mg/kg of BW daily
Number of subjects: 48

Group type: COMPARATOR
Intervention: Mixed tocopherols (TMIX)
Number of subjects: 48
Study: 34546807

Group type: EXPERIMENTAL
Intervention: RD-PAD (SmartDrive system)
Number of subjects: 22
Study: 36308112

Group type: EXPERIMENTAL
Intervention: Temporal incisions
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Chevron incisions
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Frown incisions
Number of subjects: 200

Group type: COMPARATOR
Intervention: Superior incisions
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Postoperative keratometry
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Uncorrected visual acuity (UCVA)
Number of subjects: 200
Study: 33752449

Group type: EXPERIMENTAL
Intervention: Sex hormone-binding globulin
Number of subjects: 2848

Group type: EXPERIMENTAL
Intervention: Total testosterone
Number of subjects: 2848

Group type: EXPERIMENTAL
Intervention: Free testosterone
Number of subjects: 2848
Study: 32043709

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with everolimus-eluting stents (n=948)
Number of subjects: 1804

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG) (n=957)
Number of subjects: 1804

Group type: EXPERIMENTAL
Intervention: Both PCI and CABG
Number of subjects: 1804
Study: 35187840

Group type: COMPARATOR
Intervention: Subthreshold Stochastic Resonance Stimulation (SBT-SRS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Above-threshold Stochastic Resonance Stimulation (AT-SRS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham (devices powered off)
Number of subjects: 16
Study: 34135190

Group type: EXPERIMENTAL
Intervention: At least one discordant morbidity
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: At least one concordant morbidity
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Any comorbidity
Number of subjects: 402

Group type: COMPARATOR
Intervention: No comorbidity
Number of subjects: 402
Study: 32527195

Group type: EXPERIMENTAL
Intervention: Expiratory Muscle Strength Training (EMST) for 4 to 8 weeks
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Expiratory Muscle Strength Training (EMST)
Number of subjects: 10
Study: 36354032

Group type: COMPARATOR
Intervention: Single dose mRNA-1273 (100 μg)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Double dose mRNA-1273 (2×100 μg)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Ad26.COV2-S vaccination
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil discontinuation (mycophenolate mofetil-)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Mycophenolate mofetil continuation (mycophenolate mofetil+)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Local adverse events after single and double dose mRNA-1273
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Serious adverse events related to vaccination
Number of subjects: 230
Study: 33546844

Group type: EXPERIMENTAL
Intervention: Peripheral nerve block (PNB) anaesthesia with ultrasound-guided popliteal sciatic and saphenous blocks using ropivacaine
Number of subjects: 150

Group type: COMPARATOR
Intervention: Spinal anaesthesia (SA) with hyperbaric bupivacaine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Peripheral nerve block (PNB) anaesthesia
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Quality of recovery scores
Number of subjects: 150
Study: 33245043

Group type: COMPARATOR
Intervention: Topical corticosteroids (mometasone furoate 0.1%) plus dummy narrowband ultraviolet B light
Number of subjects: 517

Group type: COMPARATOR
Intervention: Narrowband ultraviolet B light (plus placebo topical corticosteroids)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Combination (topical corticosteroids plus narrowband ultraviolet B light)
Number of subjects: 517
Study: 35176767

Group type: EXPERIMENTAL
Intervention: Morning cold exposure (7:45 am)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Evening cold exposure (7:45 pm)
Number of subjects: 24
Study: 32019356

Group type: EXPERIMENTAL
Intervention: Readmitted patients
Number of subjects: 50
Study: 35426086

Group type: EXPERIMENTAL
Intervention: Red line incision approach
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (facelift incision without red line)
Number of subjects: 24
Study: 34411635

Group type: EXPERIMENTAL
Intervention: Palonosetron
Number of subjects: 112

Group type: COMPARATOR
Intervention: Ondansetron
Number of subjects: 112
Study: 36203215

Group type: EXPERIMENTAL
Intervention: Family-based cognitive behavioural therapy (FCBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Family-based psychoeducation/relaxation training (FPRT)
Number of subjects: 0
Study: 35122097

Group type: EXPERIMENTAL
Intervention: 6 g/day of MCTs at breakfast
Number of subjects: 40

Group type: COMPARATOR
Intervention: 6 g/day of MCTs at dinnertime (positive control group)
Number of subjects: 40
Study: 32766683

Group type: EXPERIMENTAL
Intervention: Pictorial warnings with graphic or 'gross' images
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pictorial warnings with direct illustrations of warning text
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pictorial warnings including people, especially youth and young adults making eye contact
Number of subjects: 30
Study: 32682416

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 149
Study: 35176037

Group type: EXPERIMENTAL
Intervention: CSD500 condom (n = 248)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard condoms (n = 252)
Number of subjects: 500